Drug Shortage Report for ZOVIRAX
Report ID | 174378 |
Drug Identification Number | 00886157 |
Brand name | ZOVIRAX |
Common or Proper name | Acyclovir Oral Suspension |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | ACYCLOVIR |
Strength(s) | 200MG |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 475ML |
ATC code | J05AB |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-11-16 |
Estimated end date | 2023-02-15 |
Actual end date | 2023-02-14 |
Shortage status | Resolved |
Updated date | 2023-02-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2023-02-15 | French | Compare |
v9 | 2023-02-15 | English | Compare |
v8 | 2023-01-25 | French | Compare |
v7 | 2023-01-25 | English | Compare |
v6 | 2022-12-21 | French | Compare |
v5 | 2022-12-21 | English | Compare |
v4 | 2022-11-17 | French | Compare |
v3 | 2022-11-17 | English | Compare |
v2 | 2022-11-11 | French | Compare |
v1 | 2022-11-11 | English | Compare |
Showing 1 to 10 of 10